Systemic therapy of brain metastases

Area of Science:

• Oncology
• Neurology
• Cancer Research

Background:

• Brain metastases are a frequent and serious complication of cancer, often leading to poor patient prognosis.
• Managing brain metastases involves a multidisciplinary strategy, including radiation, surgery, and systemic therapy.
• Traditional systemic therapies face challenges due to the blood-brain barrier and patient pre-treatment, limiting efficacy.

Purpose of the Study:

• To review recent advancements in systemic therapies for brain metastases.
• To discuss the evidence supporting the use of novel systemic agents in managing brain metastases.
• To highlight the evolving role of immunotherapy and targeted therapies in upfront brain metastasis treatment.

Main Methods:

• Literature review of recent studies on systemic therapies for brain metastases.
• Analysis of evidence for immunotherapy and targeted therapies in brain metastasis management.
• Synthesis of data on overcoming blood-brain barrier challenges with newer agents.

Main Results:

• Newer systemic agents, particularly immunotherapy and targeted therapies, show increasing importance in treating brain metastases.
• These advanced therapies offer improved efficacy compared to conventional chemotherapy in certain patient populations.
• Advances in systemic therapy are changing the landscape of upfront management for brain metastases.

Conclusions:

• Systemic therapies, especially immunotherapy and targeted agents, are crucial for improving outcomes in brain metastases.
• Overcoming the blood-brain barrier and addressing patient heterogeneity are key focuses in current research.
• The review underscores the growing role and evidence base for novel systemic treatments in brain metastasis care.